Non-imidazole heterocyclic compounds as histamine H3-receptor ligands

Details for Australian Patent Application No. 2005230902 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Shah, Chandravadan R.; Swanson, Devin M.; Carruthers, Nicholas I.

Agent Shelston IP

Pub. Number AU-A-2005230902

PCT Pub. Number WO2005/097751

Priority 60/557,959 31.03.04 US

Filing date 31 March 2005

Wipo publication date 20 October 2005

International Classifications

C07D 213/83 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/38 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/65 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 241/24 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 261/12 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/097751 Priority application(s): WO2005/097751

27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230907-Optimized expression of HPV 52 L1 in yeast

2005230901-Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)